Precision BioSciences Inc
Ownership
Ownership Structure
Who owns Precision BioSciences Inc (DTIL)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 92.2% of the shares are freely tradable; institutional investors hold 65.6%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Aberdeen Group PLC | 8.08 | 2,230,178 | +0.0 | 06/30/2026 |
| Bleichroeder LP | 7.31 | 2,018,190 | +21.4 | 06/30/2026 |
| Octagon Capital Advisors LP | 4.89 | 1,350,000 | -39.6 | 06/30/2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | 4.88 | 1,346,004 | +26.3 | 06/30/2026 |
| BlackRock Inc | 4.25 | 1,172,873 | +487.1 | 06/30/2026 |
| Vanguard Capital Management, LLC | 4.04 | 1,116,241 | +22.6 | 06/30/2026 |
| Lynx1 Capital Management, LP | 3.44 | 950,466 | -3.5 | 06/30/2026 |
| Driehaus Capital Management LLC | 3.43 | 946,707 | -4.9 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| abrdn World Healthcare | 4.15 | 1,144,208 | +0.0 | 09/30/2026 |
| abrdn Life Sciences Investors | 3.93 | 1,085,970 | +0.0 | 09/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Germano Geno J | Director | 47,492 | 332,444 $ | Sep 25, 2026 | direct |
| Brown Melinda | Director | 45,481 | 318,367 $ | Sep 25, 2026 | direct |
| Frankel Stanley | Director | 41,478 | 290,346 $ | Sep 28, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 28, 2026 | Frankel Stanley | Director | Buy | 1,000 | 6.00 | 6,000 |
| Sep 25, 2026 | Brown Melinda | Director | Buy | 1,135 | 6.27 | 7,116 |
| Sep 25, 2026 | Germano Geno J | Director | Buy | 2,609 | 6.28 | 16,385 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.